| Company Name: |
Wuxi Zhongkun Biochemical Technology Co., Ltd.
|
| Tel: |
0510-85629785 18013409632 |
| Email: |
sales@reading-chemicals.com |
| Products Intro: |
Product Name:methyl (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate hydrochloride
CAS:57130-30-0
Purity:95%+ Package:根据客户需求包装
|
|
| | 16,17-Dihydroapovincamine Basic information |
| Product Name: | 16,17-Dihydroapovincamine | | Synonyms: | 16,17-Dihydroapovincamine;Vinpocetine Impurity 8;Vinpocetine Impurity 15 HCl;Vinpocetine-22;Eburnamenine-14-carboxylic acid, 14,15-dihydro-, methyl ester, (3α,16α);Eburnamenine-14-carboxylic acid, 14,15-dihydro-, methyl ester, (3α,16α)- (9CI) | | CAS: | 57130-30-0 | | MF: | C21H26N2O2 | | MW: | 338.44 | | EINECS: | | | Product Categories: | | | Mol File: | 57130-30-0.mol |  |
| | 16,17-Dihydroapovincamine Chemical Properties |
| | 16,17-Dihydroapovincamine Usage And Synthesis |
| Uses | 16,17-Dihydroapovincamine is an impurity of Vincamine (V314030) is often used as a nootropic agent to combat the effects of aging, or in conjunction with other nootropics (such as piracetam) for a variety of purposes. Vincamine is a peripheral vasodilator that increases blood flow to the brain. |
| | 16,17-Dihydroapovincamine Preparation Products And Raw materials |
|
|
Tag:16,17-Dihydroapovincamine(57130-30-0)
Related Product Information
|
|
methyl (41R,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
ApovincaMinic Acid Ethyl Ester N-Oxide
(3alpha,16alpha)-eburnamenine-14-carboxylic acid
methyl (41R,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
Vinpocetine
(41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid
ethyl (41S,13aR)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(-)-DihydroapovincaMinic Acid Ethyl Ester
methyl (41R,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-8-methoxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
methyl (41S,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
ethyl apovincaminate
apovincamine
methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
sodium (41S,13aS)-13a-ethyl-2,3,41,5,6,12,13,13a-octahydro- 1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12- carboxylate
ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
EBURNAMENINE-14-CARBOXYLIC ACID, 14,15-DIHYDRO-14-HYDROXY-, ETHYL ESTER, (3A,14B,16A)-
methyl (41S,12R,13aR)-13a-ethyl-12-
hydroxy-2,3,41,5,6,12,13,13aoctahydro-
1H-indolo[3,2,1-
de]pyrido[3,2,1-ij][1,5]naphthyridine-
12-carboxylate
|